Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Masimo Corporation (MASI : NSDQ)
 
 • Company Description   
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.

Number of Employees: 6,200

 
 • Price / Volume Information   
Yesterday's Closing Price: $141.23 Daily Weekly Monthly
20 Day Moving Average: 1,232,354 shares
Shares Outstanding: 55.50 (millions)
Market Capitalization: $7,838.83 (millions)
Beta: 1.00
52 Week High: $305.21
52 Week Low: $112.07
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 8.31% 21.98%
12 Week -8.30% 0.81%
Year To Date -51.76% -41.00%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
52 DISCOVERY
-
IRVINE,CA 92618
USA
ph: 949-297-7000
fax: 949-297-7001
ekammerman@masimo.com http://www.masimo.com
 
 • General Corporate Information   
Officers
Joe Kiani - Chief Executive Officer; Chairman
Micah Young - Executive Vice President; Chief Financial Officer
H Michael Cohen - Director
Adam Mikkelson - Director
Craig Reynolds - Director

Peer Information
Masimo Corporation (ABMD)
Masimo Corporation (DMDS)
Masimo Corporation (CPWY.)
Masimo Corporation (EQUR)
Masimo Corporation (ECIA)
Masimo Corporation (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 574795100
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/26/22
Share - Related Items
Shares Outstanding: 55.50
Most Recent Split Date: (:1)
Beta: 1.00
Market Capitalization: $7,838.83 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.19 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $4.61 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/26/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 30.66
Trailing 12 Months: 35.13
PEG Ratio: -
Price Ratios
Price/Book: 4.95
Price/Cash Flow: 29.39
Price / Sales: 6.30
EPS Growth
vs. Year Ago Period: 3.33%
vs. Previous Quarter: -23.14%
Sales Growth
vs. Year Ago Period: 1.74%
vs. Previous Quarter: -7.12%
ROE
03/31/22 - 15.46
12/31/21 - 16.06
09/30/21 - 15.56
ROA
03/31/22 - 12.78
12/31/21 - 13.29
09/30/21 - 12.88
Current Ratio
03/31/22 - 4.82
12/31/21 - 4.63
09/30/21 - 4.98
Quick Ratio
03/31/22 - 3.98
12/31/21 - 3.87
09/30/21 - 4.10
Operating Margin
03/31/22 - 18.61
12/31/21 - 18.59
09/30/21 - 18.04
Net Margin
03/31/22 - 17.91
12/31/21 - 18.53
09/30/21 - 19.23
Pre-Tax Margin
03/31/22 - 21.58
12/31/21 - 22.14
09/30/21 - 21.91
Book Value
03/31/22 - 28.50
12/31/21 - 28.00
09/30/21 - 26.59
Inventory Turnover
03/31/22 - 2.08
12/31/21 - 2.09
09/30/21 - 2.03
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©